A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
US: FDA approval not reviewed here
The registry reports active not recruiting. This is trial metadata, not an assessment of treatment benefit.
Phase 2 · Ongoing, no longer enrolling
Registry enrollment: 247 participants
Study ages: 18 Years to 75 Years
No results-posting date in this record
Read trial record and resultsChecked Nov 17, 2026